While Globus Medical Inc has underperformed by -1.34%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GMED fell by -27.93%, with highs and lows ranging from $94.93 to $51.79, whereas the simple moving average fell by -12.65% in the last 200 days.
On May 27, 2025, BTIG Research Downgraded Globus Medical Inc (NYSE: GMED) to Neutral. A report published by BofA Securities on January 10, 2025, Upgraded its rating to ‘Neutral’ for GMED. Morgan Stanley also Upgraded GMED shares as ‘Overweight’, setting a target price of $100 on the company’s shares in a report dated December 02, 2024. Wells Fargo August 07, 2024d the rating to Overweight on August 07, 2024, and set its price target from $60 to $78. Piper Sandler May 20, 2024d its ‘Neutral’ rating to ‘Overweight’ for GMED, as published in its report on May 20, 2024. BTIG Research’s report from March 18, 2024 suggests a price prediction of $60 for GMED shares, giving the stock a ‘Buy’ rating. ROTH MKM also rated the stock as ‘Buy’.
Analysis of Globus Medical Inc (GMED)
Further, the quarter-over-quarter increase in sales is 18.37%, showing a positive trend in the upcoming months.
One of the most important indicators of Globus Medical Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 8.62% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.26, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and GMED is recording 1.43M average volume. On a monthly basis, the volatility of the stock is set at 2.66%, whereas on a weekly basis, it is put at 3.23%, with a gain of 2.67% over the past seven days. Furthermore, long-term investors anticipate a median target price of $79.78, showing growth from the present price of $59.61, which can serve as yet another indication of whether GMED is worth investing in or should be passed over.
How Do You Analyze Globus Medical Inc Shares?
The Medical Devices market is dominated by Globus Medical Inc (GMED) based in the USA. When comparing Globus Medical Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 23.01, there is a growth in quarterly earnings of 540.84%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 17.20%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 85.12% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
